The fate of nanocarriers as nanomedicines in vivo: important considerations and biological barriers to overcome.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Current Medicinal Chemistry

• Publication date

  2013-06-30

• Fields of study

  Medicine, Materials Science, Chemistry, Computer Science

• Identifiers
  DOI 10.2174/0929867311320220003PMID 23627938
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Shape-dependent cellular processing of polyelectrolyte capsules.

  2013cited by this paper
• Challenges in design of translational nanocarriers.

  2012cited by this paper
• Surface functionalization of nanoparticles for nanomedicine.

  2012cited by this paper
• A novel chimeric cell-penetrating peptide with membrane-disruptive properties for efficient endosomal escape.

  2012cited by this paper
• Intracellular partitioning of cell organelles and extraneous nanoparticles during mitosis.

  2012cited by this paper
• Genotoxicity of Metal Nanoparticles: Focus on In Vivo Studies

  2012cited by this paper
• The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy.

  2012cited by this paper
• Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake.

  2012cited by this paper
• Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution.

  2012cited by this paper
• Drug-loaded nanocarriers: passive targeting and crossing of biological barriers.

  2012cited by this paper
• Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles.

  2012cited by this paper
• Acidic Nanoparticles Are Trafficked to Lysosomes and Restore an Acidic Lysosomal pH and Degradative Function to Compromised ARPE-19 Cells

  2012cited by this paper
• Cell Penetrating Peptides in the Delivery of Biopharmaceuticals

  2012cited by this paper
• Novel approaches for drug delivery systems in nanomedicine: effects of particle design and shape.

  2012cited by this paper
• Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing.

  2012cited by this paper
• Endocytosis at the nanoscale.

  2012cited by this paper
• Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor.

  2012cited by this paper
• Caveolae create local signalling domains through their distinct protein content, lipid profile and morphology.

  2012cited by this paper
• PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics.

  2012cited by this paper
• Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug delivery.

  2012cited by this paper
• Peptide vectors for the nonviral delivery of nucleic acids.

  2012cited by this paper
• Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.

  2012cited by this paper
• Molecular buckets: cyclodextrins for oral cancer therapy.

  2012cited by this paper
• Nanotechnological advances for the delivery of CNS therapeutics.

  2012cited by this paper
• Administration, distribution, metabolism and elimination of polymer therapeutics.

  2012cited by this paper
• Modern methods for delivery of drugs across the blood-brain barrier.

  2012cited by this paper
• The journey of a drug-carrier in the body: an anatomo-physiological perspective.

  2012cited by this paper
• Monosaccharides versus PEG-functionalized NPs: influence in the cellular uptake.

  2012cited by this paper
• Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment.

  2012cited by this paper
• Engineered nanostructural materials for application in cancer biology and medicine

  2012cited by this paper
• Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo.

  2012cited by this paper
• Formation, characterization, and fate of inhaled drug nanoparticles.

  2011cited by this paper
• Effect of gold nanoparticle aggregation on cell uptake and toxicity.

  2011cited by this paper
• Targeted Nanocarriers for Imaging and Therapy of Vascular Inflammation.

  2011cited by this paper
• PEGylated inorganic nanoparticles.

  2011cited by this paper
• Clathrin-independent endocytosis: mechanisms and function.

  2011cited by this paper
• Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles.

  2011cited by this paper
• Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages.

  2011cited by this paper
• Pathogen-mimetic stealth nanocarriers for drug delivery: a future possibility.

  2011cited by this paper
• Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population.

  2011cited by this paper
• Endosomal escape pathways for delivery of biologicals.

  2011cited by this paper
• Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer.

  2011cited by this paper
• Intratumoral Drug Delivery with Nanoparticulate Carriers

  2011cited by this paper
• Gold nanoparticles induce autophagosome accumulation through size-dependent nanoparticle uptake and lysosome impairment.

  2011cited by this paper
• Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles.

  2011cited by this paper
• Macropinocytosis: an endocytic pathway for internalising large gulps

  2011cited by this paper
• Toxicological effects of titanium dioxide nanoparticles: a review of in vitro mammalian studies.

  2011cited by this paper
• Direct Translocation as Major Cellular Uptake for CADY Self-Assembling Peptide-Based Nanoparticles

  2011cited by this paper
• Physical and chemical stability of drug nanoparticles.

  2011cited by this paper
• Superior preclinical efficacy of gemcitabine developed as chitosan nanoparticulate system.

  2011cited by this paper
• Molecular mechanism and physiological functions of clathrin-mediated endocytosis

  2011cited by this paper
• More effective nanomedicines through particle design.

  2011cited by this paper
• Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery.

  2011cited by this paper
• Polymer therapeutics as nanomedicines: new perspectives.

  2011cited by this paper
• The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect.

  2011cited by this paper
• Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines.

  2011cited by this paper
• Nanomedicine(s) under the microscope.

  2011cited by this paper
• Supramolecular nanodevices: from design validation to theranostic nanomedicine.

  2011cited by this paper
• Protein-nanoparticle interactions: opportunities and challenges.

  2011cited by this paper
• Engineering cell surfaces via liposome fusion.

  2011cited by this paper
• Deep penetration of a PDT drug into tumors by noncovalent drug-gold nanoparticle conjugates.

  2011cited by this paper
• Fate and toxicity of metallic and metal-containing nanoparticles for biomedical applications.

  2011cited by this paper
• Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size.

  2011cited by this paper
• Theranostic Applications of Nanomaterials in Cancer: Drug Delivery, Image-Guided Therapy, and Multifunctional Platforms

  2011cited by this paper
• Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis.

  2011cited by this paper
• Adsorption and conformation of serum albumin protein on gold nanoparticles investigated using dimensional measurements and in situ spectroscopic methods.

  2011cited by this paper
• Progressive severe lung injury by zinc oxide nanoparticles; the role of Zn2+ dissolution inside lysosomes

  2011cited by this paper
• Extravasation of polymeric nanomedicines across tumor vasculature.

  2011cited by this paper
• Nuclear drug delivery for cancer chemotherapy.

  2011cited by this paper
• Interaction of densely polymer-coated gold nanoparticles with epithelial Caco-2 monolayers.

  2011cited by this paper
• Polymer particles that switch shape in response to a stimulus

  2010cited by this paper
• Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles

  2010cited by this paper
• Targeted Liposomal Drug Delivery to Monocytes and Macrophages

  2010cited by this paper
• The highly efficient delivery of exogenous proteins into cells mediated by biodegradable chimaeric polymersomes.

  2010cited by this paper
• Molecules, mechanisms, and cellular roles of clathrin-independent endocytosis.

  2010cited by this paper
• Efficient gene transfection by histidine-modified chitosan through enhancement of endosomal escape.

  2010cited by this paper
• Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy.

  2010cited by this paper
• What the cell "sees" in bionanoscience.

  2010cited by this paper
• Receptor-Mediated and Fluid-Phase Transcytosis of Horseradish Peroxidase across Rat Hepatocytes

  2010cited by this paper
• Endocytosis and Intracellular Distribution of PLGA Particles in Endothelial Cells: Effect of Particle Geometry.

  2010cited by this paper
• Effect of nanoparticle surface charge at the plasma membrane and beyond.

  2010cited by this paper
• In vivo biodistribution and efficacy of peptide mediated delivery.

  2010cited by this paper
• Intracellular nanoparticle coating stability determines nanoparticle diagnostics efficacy and cell functionality.

  2010cited by this paper
• Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers

  2010cited by this paper
• Interaction of gold nanoparticles with common human blood proteins.

  2010cited by this paper
• Design of oral insulin delivery systems

  2010cited by this paper
• Exploring the caves: cavins, caveolins and caveolae.

  2010cited by this paper
• Caveolae at a glance

  2010cited by this paper
• Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery.

  2010cited by this paper
• The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function.

  2010cited by this paper
• Cell penetrating peptides: overview and applications to the delivery of oligonucleotides

  2010cited by this paper
• Gene Transfer: How Can the Biological Barriers Be Overcome?

  2010cited by this paper
• Frontiers in cancer nanomedicine: directing mass transport through biological barriers.

  2010cited by this paper
• Strategies in the design of nanoparticles for therapeutic applications

  2010cited by this paper
• Caveolin-1 is ubiquitinated and targeted to intralumenal vesicles in endolysosomes for degradation

  2010cited by this paper
• Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection.

  2010cited by this paper
• Endosome‐disruptive peptides for improving cytosolic delivery of bioactive macromolecules

  2010cited by this paper
• Physiologically based pharmacokinetic modeling of nanoparticles.

  2010cited by this paper
• The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability.

  2010cited by this paper
• Lysosomal degradation of the carboxydextran shell of coated superparamagnetic iron oxide nanoparticles and the fate of professional phagocytes.

  2010cited by this paper

• Recent Advances and Applications of Semiconducting Polymer Nanomaterials in Cancer Therapy

  2025cites this paper
• Pharmacokinetic modeling in drug delivery system

  2025cites this paper
• Interplay Between Diabetes, Obesity and Glioblastoma Multiforme, and the Role of Nanotechnology in Its Treatment

  2025cites this paper
• Nanocarriers to mediate the pathways from diabetes toward Parkinson's disease

  2024cites this paper
• Latest developments in biomaterial interfaces and drug delivery: challenges, innovations, and future outlook

  2024cites this paper
• Advanced Applications of Nanomaterials in Atherosclerosis Diagnosis and Treatment: Challenges and Future Prospects.

  2024cites this paper
• Nanomaterials to prevent progression of glioblastoma multiforme from diabetes mellitus

  2024cites this paper
• Unraveling the Ties: Type 2 Diabetes and Parkinson's Disease - A Nano-Based Targeted Drug Delivery Approach.

  2024cites this paper
• Multiscale physics-based in silico modelling of nanocarrier-assisted intravascular drug delivery

  2024cites this paper
• Application of Computing as a High-Practicability and -Efficiency Auxiliary Tool in Nanodrugs Discovery

  2023cites this paper
• Microfluidic devices for the detection of disease-specific proteins and other macromolecules, disease modelling and drug development: A review.

  2023cites this paper
• Application of nanomaterials for drug delivery

  2023cites this paper
• Chemical, physical, and biological stimuli-responsive nanogels for biomedical applications (mechanisms, concepts, and advancements): A review.

  2023cites this paper
• Recent Advances in Endocannabinoid System Targeting for Improved Specificity: Strategic Approaches to Targeted Drug Delivery

  2022cites this paper
• Placental Models for Evaluation of Nanocarriers as Drug Delivery Systems for Pregnancy Associated Disorders

  2022cites this paper
• Rational nanocarrier design towards clinical translation of cancer nanotherapy

  2021cites this paper
• Recent Advances in Microfluidics for the Preparation of Drug and Gene Delivery Systems.

  2020cites this paper
• Absorption, distribution, metabolism, and excretion of nanocarriers in vivo and their influences.

  2020cites this paper
• Bone-targeting polymer vesicles for simultaneous imaging and effective malignant bone tumor treatment.

  2020cites this paper
• Natural Polysaccharides for siRNA Delivery: Nanocarriers Based on Chitosan, Hyaluronic Acid, and Their Derivatives

  2019cites this paper
• Resveratrol loaded glycyrrhizic acid-conjugated human serum albumin nanoparticles for tail vein injection II: pharmacokinetics, tissue distribution and bioavailability

  2019cites this paper
• Absorption, distribution, metabolism and excretion of the biomaterials used in Nanocarrier drug delivery systems.

  2019cites this paper
• Phase transfer-driven rapid and complete ligand exchange for molecular assembly of phospholipid bilayers on aqueous gold nanocrystals.

  2019cites this paper
• Effective in Vitro Photokilling by Cell-Adhesive Gold Nanorods

  2018cites this paper
• Stimuli‐responsive nanocarriers for delivery of bone therapeutics – Barriers and progresses

  2018cites this paper
• Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases.

  2017cites this paper
• Targeted Nanoparticles for the Treatment of Alzheimer's Disease.

  2017cites this paper
• Research Journal of Pharmaceutical , Biological and Chemical Sciences Nanotechnology For Regenerative Medicine In Cardiovascular Diseases : An Updated Review

  2017cites this paper
• New active formulations against M. tuberculosis: Bedaquiline encapsulation in lipid nanoparticles and chitosan nanocapsules

  2017cites this paper
• Nanoparticles as a Technology Platform for Biomedical Imaging

  2017cites this paper
• Gold-nanoparticles coated with the antimicrobial peptide esculentin-1a(1-21)NH2 as a reliable strategy for antipseudomonal drugs.

  2017cites this paper
• New active formulations against M. tuberculosis: Bedaquiline encapsulation in lipid nanoparticles and chitosan nanocapsules

  2017cites this paper
• “Gold Nanoprism-Nanorod Face Off: Comparing the heating efficiency, cellular internalisation and thermoablation capacity of gold nanorods and nanoprisms”

  2017cites this paper
• Gold nanoprism-nanorod face off: comparing the heating efficiency, cellular internalization and thermoablation capacity.

  2016cites this paper
• Strategies to enhance nanoparticle-endothelial interactions under flow

  2016cites this paper
• Surface engineered magnetic nanoparticles for specific immunotargeting of cadherin expressing cells

  2016cites this paper
• Particle size dependent photodynamic anticancer activity of hematoporphyrin-conjugated Fe 3 O 4 particles

  2016cites this paper
• Controlling Properties and Cytotoxicity of Chitosan Nanocapsules by Chemical Grafting

  2016cites this paper
• Nanotherapeutics: From Laboratory to Clinic

  2016cites this paper
• Shape matters: synthesis and biomedical applications of high aspect ratio magnetic nanomaterials.

  2015cites this paper
• Novel methodology for labelling mesoporous silica nanoparticles using the 18F isotope and their in vivo biodistribution by positron emission tomography

  2015influential citation
• Peptide gH625 enters into neuron and astrocyte cell lines and crosses the blood–brain barrier in rats

  2015cites this paper
• Sodium-22-radiolabeled silica nanoparticles as new radiotracer for biomedical applications: in vivo positron emission tomography imaging, biodistribution, and biocompatibility

  2015cites this paper
• Cationic carbosilane dendrimers and oligonucleotide binding: an energetic affair.

  2015cites this paper
• -Iodolactone, key mediator of antitumoral properties of iodine

  2014cites this paper
• Nanofiber scaffolds for treatment of spinal cord injury.

  2014cites this paper
• Exploitation of viral properties for intracellular delivery‡

  2014cites this paper
• Strategies for the biofunctionalization of gold and iron oxide nanoparticles.

  2014cites this paper